marketcaparena
Search

    LABT

    Lakewood-Amedex Biotherapeutics Inc.

    Company overview

    Market capitalization
    $2.73M
    Employees
    5
    Latest publication
    2026-09-29
    About Lakewood-Amedex Biotherapeutics Inc.

    Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers, which is in Phase 2b clinical trial. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
    Total Revenue0USD0USD0USD0USD0USD
    Research Development182,147USD185,730USD752,931USD169,703USD432,594USD
    Selling General Administrative703,444USD525,172USD1,126,227USD371,747USD428,424USD
    Other Operating Expenses886,750USD————
    Total Operating Expenses886,750USD712,060USD1,880,317USD542,609USD862,176USD
    Operating Income-886,750USD-712,060USD-1,880,317USD-542,609USD-862,176USD
    Interest Income1,078USD4,950USD10,966USD4,307USD7,637USD
    Interest Expense38,219USD37,808USD37,808USD1,315USD0USD
    Net Interest Income-37,141USD-32,858USD-26,842USD2,992USD7,637USD
    Income Before Tax-923,291USD-744,918USD-1,907,159USD-539,617USD-854,539USD
    Net Income-923,291USD-744,918USD-1,907,159USD-539,617USD-854,539USD
    Net Income From Continuing Ops-923,291USD-744,918USD-1,907,159USD-539,617USD-854,539USD
    Ebit-887,350USD————
    Ebitda-886,191USD————
    Depreciation And Amortization1,159USD————
    Reconciled Depreciation30,492USD30,290USD1,159USD29,701USD29,511USD
    Total Other Income Expense Net-36,541USD———0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Total Revenue0USD0USD0USD
    Research Development1,255,266USD2,103,366USD5,528,948USD
    Selling General Administrative2,512,470USD1,917,154USD3,096,208USD
    Total Operating Expenses3,772,370USD4,026,820USD8,636,719USD
    Operating Income-3,772,370USD-4,026,820USD-8,636,719USD
    Interest Income25,614USD142,596USD360,122USD
    Interest Expense100,881USD5,000USD10,000USD
    Net Interest Income-75,267USD137,596USD350,122USD
    Income Before Tax-3,847,637USD-4,855,405USD-8,281,960USD
    Net Income-3,847,637USD-4,855,405USD-8,281,960USD
    Net Income From Continuing Ops-3,847,637USD-4,855,405USD-8,281,960USD
    Reconciled Depreciation119,976USD118,594USD120,985USD
    Total Other Income Expense Net—-966,181USD4,637USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ4 20242024-12-31 · USD
    Total Assets4,960,009USD196,343USD481,598USD985,118USD1,070,581USD
    Cash And Equivalents2,584,774USD————
    Cash And Short Term Investments4,584,774USD11,709USD———
    Short Term Investments2,000,000USD———0USD
    Total Current Assets4,845,299USD50,626USD305,389USD778,204USD773,981USD
    Other Current Assets255,999USD38,917USD68,989USD119,794USD92,883USD
    Other Non Current Assets7,821USD————
    Total Liabilities628,926USD————
    Total Current Liabilities628,926USD3,027,696USD2,405,100USD2,180,001USD500,628USD
    Total Stockholder Equity4,331,083USD-2,841,648USD-1,964,537USD-1,266,316USD409,611USD
    Total Equity Including Noncontrolling Interest4,331,083USD————
    Property Plant Equipment Net106,889USD8,066USD168,077USD198,367USD288,053USD
    Accounts Payable165,942USD547,829USD381,041USD278,774USD166,467USD
    Short Term Debt101,619USD1,746,044USD———
    Common Stock217USD704USD———
    Retained Earnings-68,639,996USD-54,274,421USD-53,351,130USD-52,606,212USD-49,503,493USD
    Total Liab—3,037,991USD2,446,135USD2,251,434USD660,970USD
    Other Current Liab—733,823USD———
    Capital Stock—3,744USD3,744USD3,744USD3,739USD
    Cash—11,709USD236,400USD658,410USD681,098USD
    Net Debt—1,744,630USD1,263,600USD841,590USD—
    Short Long Term Debt—1,625,000USD1,500,000USD1,500,000USD—
    Short Long Term Debt Total—1,756,339USD———
    Property Plant Equipment Gross—137,585USD236,256USD265,388USD351,598USD
    Common Stock Shares Outstanding—699,546shares13,935,640shares13,935,640shares13,935,640shares
    Non Current Assets Total—145,717USD176,209USD206,914USD296,600USD
    Non Current Liabilities Total—10,295USD41,035USD71,433USD160,342USD
    Non Currrent Assets Other—137,651USD8,132USD8,547USD8,547USD
    Net Working Capital—-2,977,070USD-2,099,711USD-1,401,797USD273,353USD
    Unclassified Current Liabilities—-1,625,000USD———
    Unclassified Equity—51,428,325USD51,382,849USD51,336,152USD49,909,365USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Total Assets481,598USD1,070,581USD6,893,904USD
    Other Current Assets68,989USD92,883USD90,089USD
    Total Liab2,446,135USD660,970USD2,335,577USD
    Total Stockholder Equity-1,964,537USD409,611USD4,558,327USD
    Capital Stock3,744USD3,739USD3,726USD
    Retained Earnings-53,351,130USD-49,503,493USD-44,648,088USD
    Cash236,400USD681,098USD2,529,756USD
    Total Current Assets305,389USD773,981USD6,480,556USD
    Total Current Liabilities2,405,100USD500,628USD2,062,715USD
    Net Debt1,263,600USD——
    Short Long Term Debt1,500,000USD—200,000USD
    Accounts Payable381,041USD166,467USD499,066USD
    Property Plant Equipment Net168,077USD288,053USD404,801USD
    Property Plant Equipment Gross236,256USD351,598USD462,046USD
    Common Stock Shares Outstanding13,935,640shares13,935,640shares13,935,640shares
    Non Current Assets Total176,209USD296,600USD413,348USD
    Non Current Liabilities Total41,035USD160,342USD272,862USD
    Non Currrent Assets Other8,132USD8,547USD8,547USD
    Net Working Capital-2,099,711USD273,353USD4,417,841USD
    Unclassified Equity51,382,849USD49,909,365USD49,202,689USD
    Short Term Investments—0USD3,860,711USD
    Unclassified Current Liabilities——1,363,649USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation2,317USD
    Stock Based Compensation107,425USD
    Change To Liabilities-157,606USD
    Change In Working Capital-406,324USD
    Operating Cash Flow-2,453,721USD
    Net Investments-2,000,000USD
    Investing Cash Flow-2,000,000USD
    Financing Cash Flow6,802,095USD
    Change In Cash2,348,374USD
    End Cash Flow2,584,774USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USD
    Net Income-923,291USD-744,918USD-1,907,159USD-539,617USD-854,539USD
    Depreciation30,492USD30,290USD—29,701USD29,511USD
    Stock Based Compensation46,180USD46,697USD—53,773USD63,199USD
    Change In Working Capital496,928USD245,921USD—52,054USD25,646USD
    Total Cash From Operating Activities-349,691USD-422,010USD—-404,089USD-738,211USD
    Capital Expenditures0USD0USD0USD0USD0USD
    Free Cash Flow-349,691USD-422,010USD—-404,089USD-738,211USD
    Net Borrowings125,000USD0USD—200,000USD—
    Total Cash From Financing Activities125,000USD0USD—200,000USD0USD
    Change In Cash-224,691USD-422,010USD—-204,089USD102,789USD
    Begin Period Cash Flow236,400USD658,410USD477,009USD681,098USD578,309USD
    End Period Cash Flow11,709USD236,400USD658,410USD477,009USD681,098USD
    Investments—0USD——841,000USD
    Sale Purchase Of Stock—0USD——0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USD
    Net Income-3,847,637USD-4,855,405USD-8,281,960USD
    Depreciation119,976USD118,594USD120,985USD
    Stock Based Compensation1,353,489USD269,669USD608,239USD
    Change In Working Capital429,474USD-1,190,381USD813,146USD
    Total Cash From Operating Activities-1,944,698USD-5,723,322USD-6,816,114USD
    Capital Expenditures0USD-1,846USD0USD
    Free Cash Flow-1,944,698USD-5,725,168USD-6,816,114USD
    Investments0USD3,926,510USD-3,784,187USD
    Net Borrowings1,500,000USD0USD—
    Total Cash From Financing Activities1,500,000USD-50,000USD0USD
    Sale Purchase Of Stock0USD-50,000USD0USD
    Change In Cash-444,698USD-1,848,658USD-10,600,301USD
    Begin Period Cash Flow681,098USD2,529,756USD13,130,057USD
    End Period Cash Flow236,400USD681,098USD2,529,756USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.